Mode
Text Size
Log in / Sign up
N/A N=5,498 Randomized Double-blind Prevention

A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women

Breast Cancer

Enrolled (actual)
5,498
Serious AEs
0.0%
Results posted
Sep 2021
Primary outcome: Primary: Percentage of Overdue Women Returning for Screening Mammography — 24.0; 34.4 percentage of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Standard Reminder Postcard (Other); Family Physician Reminder Letter (Other)
Age
Adult, Older Adult · 51+ yrs
Sex
Female
Sponsor
British Columbia Cancer Agency
Primary completion
Dec 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Overdue Women Returning for Screening Mammography
24.0; 34.4

Summary

A randomized, double-blinded study conducted in British Columbia, Canada, where there is a publicly funded, organized screening program and screening mammography is recommended at 24-month intervals. Eligible women aged 51-73 years old and overdue for their screening mammogram by 6-24 months are identified in the database of the Screening Mammography Program of BC (SMPBC). Family physicians are recruited by mail and asked to sign letters to the overdue women in their practices. The overdue women are randomized and mailed either the signed reminder letter and the standard reminder postcard, or the standard reminder postcard alone. The primary endpoint is the proportion of overdue women attending a screening mammogram appointment 6 months after the mailing.

Eligibility Criteria

Inclusion Criteria

Active family physicians (family physicians, general practitioners or primary care physicians) who have overdue women in their practice that meet the following criteria:

  • Previously been enrolled in the SMPBC and had a previous normal screening mammogram.
  • Have agreed to being contacted for research on the SMPBC questionnaire
  • Are 6-24 months overdue from their last screening mammogram
  • Live in BC
  • Have listed an active family physician as the contact to receive their mammography results

Exclusion Criteria

  • Family physicians who do not work in primary care
  • Family physicians who do not have overdue women in their practice
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02660788). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search